Geode Capital Management »

4d Molecular Therapeutics In shares owned by Geode Capital Management

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $22M 1.1M 20.99
2024-03-31 $28M 873k 31.86
2023-09-30 $9.4M 742k 12.73
2023-06-30 $13M 690k 18.07
2023-03-31 $9.9M 578k 17.19
2022-12-31 $13M 562k 22.21
2022-09-30 $4.3M 529k 8.04
2022-06-30 $3.4M 493k 6.98
2022-03-31 $7.2M 479k 15.12
2021-12-31 $11M 482k 21.94
2021-09-30 $9.2M 342k 26.97
2021-06-30 $4.0M 167k 24.08
2021-03-31 $6.3M 146k 43.38
2020-12-31 $529k 13k 41.39